File Format: PDF/Adobe Acrobat - Quick View

4 days ago – Abbott Park, Illinois (NYSE: ABT) — Abbott announced today that the investigational ABSORB™ bioresorbable vascular scaffold (BVS) has .

Abbott announced today that it has received CE Mark approval for the world's first drug eluting bioresorbable vascular scaffold (BVS) for the treatment of .

Apr 4, 2011 – NEW ORLEANS, April 3, 2011 /PRNewswire/ -- Abbott today announced . trial with 30 patients demonstrated that Abbott's BVS successfully treated . Abbott Vascular is a global leader in cardiac and vascular care with .

Title: Global Product Marketing Manager (BVS) at Abbott Vascular; Demographic info: San Francisco Bay Area | Medical Devices. View Full Profile .

Sep 22, 2010 – At nine months, Abbott's bioresorbable vascular scaffold (BVS) demonstrated strong results that remained consistent with the six-month data .

May 11, 2011 – Abbott Labs Vascular division. abbott vascular - Google News . Medgadget.com The ABSORB bioresorbable vascular scaffold (BVS)… 9/12/ .

Apr 3, 2011 – Abbott's ABSORB Bioresorbable Vascular Scaffold Demonstrates .

File Format: PDF/Adobe Acrobat - Quick View

by J Gomez-Lara - 2010 - Cited by 2 - Related articles

Sep 8, 2011 – In January 2011, Abbott Vascular received CE Mark approval for the Absorb BVS for the treatment of coronary artery disease. In the United .

Aug 16, 2011 – Abbott's BVS restores blood flow by opening a clogged vessel and . Abbott Vascular is a global leader in cardiac and vascular care with .

320+ items – Abbott Laboratories - Database of Clinical Trials by .

At nine months, Abbott's bioresorbable vascular scaffold (BVS) demonstrated strong results that remained consistent with the six-month data from the same .

Will prescribe BVS stent as opposed to a typical DES such as Cypher. Cardiac death – anyone who . . Jennie Kim, Abbott Vascular, U.S.A. Dr. Robert Cottone .

File Format: PDF/Adobe Acrobat - Quick View

Nov 8, 2010 – After a number of years, one stent, a fully bioabsorbable everolimus-eluting stent (BVS, Abbott Vascular) shows promise and is furthest along in .

2 days ago – ENP Newswire - 18 October 2011 Release date- 17102011 - Abbott Park . investigational ABSORB bioresorbable vascular scaffold (BVS) has .

Aug 16, 2011 – The first patient in Japan has been treated with Abbott ($ABT) Vascular's ABSORB bioresorbable vascular scaffold (BVS), which restores blood .

markt-studie.de : Abbott Vascular Inc. - Product Pipeline Analysis (2011) . Absorb - Bioabsorbable Vascular Solutions (BVS) EECSS First In Man Clinical .

Aug 16, 2011 – Abbott's BVS restores blood flow by opening a clogged vessel and . Abbott Vascular is a global leader in cardiac and vascular care with .

May 28, 2010 – At six months, Abbott's bioresorbable vascular scaffold (BVS) demonstrated strong results, with a low (4.4%) rate of major adverse cardiac .

by J Gomez-Lara - 2010 - Cited by 2 - Related articles

4 days ago – Abbott's ABSORB™ Bioresorbable Vascular Scaffold Honored with . the investigational ABSORB™ bioresorbable vascular scaffold (BVS) has .

Abbott Vascular's Xience V Drug-Eluting Stent Experiences Rapid Adoption During . . Vascular Scaffold (BVS) for the treatment of coronary artery disease. .

Aug 16, 2011 – Abbott's BVS restores blood flow by opening a clogged vessel and . Abbott Vascular is a global leader in cardiac and vascular care with .

Sep 17, 2010 – The ABSORB trial is evaluating Abbott's bioresorbable vascular scaffold (BVS), which aims to restore blood flow by opening a clogged vessel .

File Format: PDF/Adobe Acrobat - View as HTML

1 day ago – Global BVS Absorb Marketing Manager Job. List all Abbott Vascular Jobs. Company - Abbott Vascular Location - Santa Clara, California US .

Jan 10, 2011 – Abbott's BVS device restores blood flow by opening a .

The bioresorbable vascular scaffold (BVS, Abbott) is made of polylactide and is designed to restore blood flow to the heart by providing additional support to .

File Format: PDF/Adobe Acrobat - Quick View

Speaker: James P. Oberhauser, Ph.D., Manager, BVS Polymer R&D, Abbott Vascular. ABSTRACT : The coupling between microstructure and macroscopic .

Jan 31, 2011 – The Abbott Vascular BVS ProgramA Fully Bioresorbable Vascular Scaffold : The Abbott Vascular BVS ProgramA Fully Bioresorbable Vascular .

4 days ago – . 2011 /PRNewswire/ -- Abbott (NYSE: ABT) announced today that the investigational ABSORB™ bioresorbable vascular scaffold (BVS) has .

Jan 11, 2011 – Abbott announced today that it has received CE Mark approval for the world's first drug eluting bioresorbable vascular scaffold (BVS) for .

File Format: PDF/Adobe Acrobat - Quick View

Aug 16, 2011 – First Patient in Japan Treated with Abbott's Bioresorbable Vascular . Abbott's BVS restores blood flow by opening a clogged vessel and .

Sep 22, 2010 – Abbott Vascular Presents ABSORB Trial Data. .

File Format: PDF/Adobe Acrobat

Aug 16, 2011 – Abbott's BVS restores blood flow by opening a clogged vessel and . Abbott Vascular is a global leader in cardiac and vascular care with .

25+ items – Device: Abbott Vascular BVS. Study Type .

. with ABSORB Bioresorbable Vascular Scaffold System (“BVS”) is considered a . AMI Care Initiatives or AMI-CI is a program of Abbott Vascular to support the .

by JA Ormiston - 2009 - Cited by 20 - Related articles

Oct 4, 2010 – Abbott's BVS is designed to restore blood flow by opening a narrowed . Abbott Vascular is a global leader in cardiac and vascular care with .

File Format: PDF/Adobe Acrobat - Quick View

Apr 3, 2011 – . with 30 patients demonstrated that Abbott's BVS successfully treated . Abbott Vascular is a global leader in cardiac and vascular care .

Sep 27, 2011 – Rotterdam, the Netherlands - New 12-month clinical data on the second iteration of the Absorb BVS Rev 1.1 (Abbott Vascular, Abbott Park, .

The ABSORB trial is evaluating Abbott's bioresorbable vascular scaffold (BVS), which aims to restore blood flow by opening a clogged vessel and providing .

Mar 15, 2010 – Patients treated with Abbott's bioresorbable vascular .

Sitemap